GleamWall
中文EN

BIOX Bioceres Crop Solutions Corp. IFRS

Agricultural Chemicals · Nasdaq · SEC CIK 1769484 · Fiscal year ends 06/30

Financial factors as of 2025-12-31 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-28.4%
TTM net income YoY-16,023.8%
TTM EPS YoY-9,660.3%
Revenue 3-yr CAGR-10.3%
Net income 3-yr CAGR—

Margins

Gross margin39.1%
Operating margin0.8%
Net margin-83.4%
FCF margin27.7%
EBITDA margin—

Returns

ROE-123.8%
ROA-34.2%
ROIC (approx.)0.5%
Asset turnover0.41x

Leverage & solvency

Liabilities / assets81.0%
Debt / equity1.63x
Current ratio0.90x
Interest coverage0.07x

Cash quality & payout

Operating cash flow / net income-0.34x
Accruals ratio-46.0%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q2*2025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-312025Q12024-09-302024Q4*2024-06-302024Q32024-03-31
Income statement
Revenue$73.81M$77.60M$74.55M$60.59M$98.80M$93.29M$123.99M$83.98M
Cost of revenue$47.15M$41.30M$49.34M$36.74M$57.26M$55.80M$76.56M$41.34M
Gross profit$26.65M$36.30M$25.21M$23.85M$41.54M$37.49M$47.43M$42.64M
R&D expense$2.35M$5.72M$2.65M$3.66M$1.97M$4.41M$5.37M$3.59M
SG&A expense$17.14M$23.14M$33.64M$26.15M$25.35M$30.16M$31.50M$27.09M
Operating income$7.52M$7.21M-$13.46M$933,210$14.36M$2.37M$9.48M$13.20M
Interest expense$7.95M$9.12M$8.14M$6.11M$6.43M$7.16M$8.16M$7.24M
Pretax income-$1.37M-$5.37M-$44.92M-$5.60M$7.30M-$7.46M-$6.11M$8.82M
Income tax$3.11M$2.08M$6.75M-$4.01M$636,153-$1.27M-$4.03M-$955,832
Net income-$182.47M-$7.33M-$47.89M-$1.30M$143,535-$6.37M-$1.53M$9.26M
EPS (basic)-2.88-0.12—-0.020.00-0.10—0.15
EPS (diluted)-2.88-0.12—-0.020.00-0.10—0.14
Weighted avg. shares (diluted)—63.43M—62.79M63.17M62.85M—66.76M
Balance sheet
Cash & equivalents$11.06M$15.51M$32.70M$38.46M$29.18M$32.28M$44.47M$16.36M
Receivables$154.93M$158.39M$165.86M$187.51M$226.46M$195.79M$207.32M$211.19M
Inventory$64.79M$88.59M$87.61M$92.02M$101.81M$117.66M$125.93M$129.16M
Current assets$294.28M$283.15M$308.31M$338.21M$382.57M$377.08M$408.67M$407.18M
PP&E, netmay include right-of-use assets (IFRS)$61.09M$74.04M$74.58M$75.34M$74.90M$74.56M$74.57M$74.56M
Goodwill$36.07M$112.16M$112.16M$112.16M$112.16M$112.16M$112.16M$112.16M
Intangibles$87.29M$178.64M$181.17M$181.82M$176.29M$175.77M$176.89M$174.45M
Total assets$560.36M$734.88M$763.65M$798.21M$835.20M$827.26M$852.55M$836.13M
Current liabilities$328.64M$299.72M$337.99M$332.31M$288.78M$295.86M$329.31M$332.97M
Short-term debt$90.06M$85.13M$119.73M$95.64M$119.19M$121.18M$136.75M$142.61M
Long-term debt$34.16M$53.80M$38.20M$75.69M$66.91M$46.06M$42.10M$20.48M
Total debt$124.22M$138.94M$157.93M$171.34M$186.11M$167.24M$178.85M$163.08M
Total liabilities$453.75M$446.55M$468.43M$453.24M$488.87M$481.23M$501.17M$487.60M
Shareholders' equity$76.41M$258.67M$265.44M$308.46M$309.55M$309.48M$315.04M$313.35M
Net debt$113.15M$123.43M$125.23M$132.88M$156.93M$134.96M$134.38M$146.72M
Cash flow statement
Operating cash flow$17.39M$14.38M$26.77M$23.34M-$5.36M$5.16M$23.26M-$17.39M
Capital expenditure-$12,473$672,115$430,670$1.28M$2.66M$1.28M$2.02M$1.70M
Free cash flow$17.40M$13.70M$26.34M$22.06M-$8.01M$3.88M$21.24M-$19.09M
Investing cash flow-$2.80M-$1.26M$1.49M-$2.50M-$5.39M$271,763-$295,058-$1.37M
Financing cash flow-$17.99M-$28.71M-$25.71M-$12.68M$6.49M-$18.80M$5.32M$10.90M
Stock-based compensation—$533$1.03M$1.01M$1.53M$809,585$2.65M$2.95M
Dividends paid——$0$0——$0$23,188
Share buybacks——$0$0——$0$0

Free plan shows the latest 8 periods; Pro shows all 20 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.